Streetbeat News

Products Services

MG

MISTRAS Group, Inc. (MG: NYSE) has announced the implementation of the first Project Phoenix initiative, a reorganization of the Company's Products & Systems segment expected to increase Adjusted EBITDA by $4.0 Million in Fiscal 2024. The company also announced the appointment of Gennaro (Jerry) D'Alterio as Executive Vice President and Chief Commercial Officer. These initiatives are part of the company's strategy to accelerate the transition into faster growing markets and improve the performance of its traditional energy-related market operations.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:16 pm

NVTA

The FDA has approved Invitae's DNA test for assessing certain cancers, leading to a rise in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:12 pm

AVGO

Broadcom Inc. (NASDAQ:AVGO) has announced the availability of its 5nm 200G/lane optical PAM-4 DSP PHY, the Sian™ BCM85822, at the 49th European Conference on Optical Communication (ECOC 2023). The new product is designed to meet the growing bandwidth needs and low power consumption requirements of hyperscale data centers. It supports optical modules from 800G to 1.6T and is optimized for the 1.6T OSFP-XD transceiver module design, enabling 51.2T switching capacity in a 1RU rack.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:12 pm

GOOG

GOOGL

Google has announced the launch of Chromebook Plus with a starting price of $399, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:10 pm

AAPL

Apple Inc.'s 16-inch 2021 MacBook Pro with the M1 Pro chip is now available at a $1,000 discount, close to its all-time low price. The deal is offered by Adorama and is applicable on the 16-inch MacBook Pro with 32GB of RAM and a 512GB SSD. The MacBook Pro is one of the more powerful MacBooks and is still considered powerful despite being a 2-year-old notebook.

Portfolio Pulse from Rounak Jain

October 02, 2023 | 1:09 pm

SAVA

Cassava Sciences has completed patient enrollment for a pivotal Phase 3 clinical trial of oral Simufilam in Alzheimer's disease with 804 patients. A second Phase 3 trial is expected to complete enrollment by Q4 2023, targeting approximately 1,100 patients.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:09 pm

CCG

XPEV

Cheche Group Inc. (NASDAQ:CCG) has expanded its partnership with Xpeng, Inc. (NYSE:XPEV) to provide insurance services for Xpeng's EVs in ten cities. Xpeng's robust sales growth, with August's G6 deliveries exceeding 7,000 units, has been accompanied by Cheche's sophisticated insurance service platform. The partnership has established a new growth model for Xpeng and integrated opportunities for Cheche's digital insurance services.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:07 pm

TSLA

Tesla has confirmed that its 2023 volume target of approximately 1.8 million vehicles remains unchanged.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:05 pm

TSLA

Tesla Inc has reported a sequential decline in Q3 Model S/X production to 13,688 units. The company attributes this decrease to planned downtimes for factory upgrades.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:04 pm

NKTR

Nektar Therapeutics (NASDAQ:NKTR) announced that it will present two abstracts on rezpegaldesleukin, a first-in-class selective regulatory T-cell therapy, at the 2023 European Academy of Dermatology and Venereology Congress. The presentations will cover Phase 1b safety and efficacy data for rezpegaldesleukin in moderate to severe atopic dermatitis and the design of a Phase 2b study. The company plans to advance the program into a robust Phase 2b study later this month.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 1:04 pm